NOISS Meridian Bioscience Inc

SOL #: W81K0026QA165Special NoticeSole Source

Overview

Buyer

DEPT OF DEFENSE
Dept Of The Army
W40M MRC0 WEST
JBSA FT SAM HOUSTON, TX, 78234-4504, United States

Place of Performance

Fort Hood, TX

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
May 27, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Medical Readiness Contracting Office – West (MRCO-W), Fort Hood Health Contracting Branch, intends to award a Firm Fixed-Price, sole source contract to Meridian Bioscience Inc. This contract is for the lease of analyzers, supply of testing reagents, and associated hardware for detecting Helicobacter pylori and Clostridioides difficile at Carl R. Darnall Army Medical Center (CRDAMC), Fort Hood, Texas. The intended award date is on or about June 26, 2026.

Scope of Work

This sole source requirement covers:

  • Lease of specialized analyzers.
  • Supply of necessary testing reagents.
  • Provision of associated testing hardware.

These items are crucial for the detection of Helicobacter pylori and Clostridioides difficile to support CRDAMC's medical operations.

Contract & Timeline

  • Type: Firm Fixed-Price, Sole Source
  • Set-Aside: Not applicable (Sole Source)
  • Intended Award Date: On or about June 26, 2026
  • Published: May 27, 2026
  • NAICS Code: 325413, "In-Vitro Diagnostic Substance Manufacturing" (Size Standard: 1,250 employees)

Evaluation

The Government has determined that only one source, Meridian Bioscience Inc., is reasonably available for this requirement, justifying a sole source award under Federal Acquisition Regulation (FAR) 12.102(a).

Additional Notes

This notice is not a request for competitive quotes. No requests for capability briefings will be honored, and any information provided will not be used for subsequent solicitations. A determination by the Government not to compete this proposed contract is solely at its discretion.

People

Points of Contact

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Special Notice
Posted: May 27, 2026
NOISS Meridian Bioscience Inc | GovScope